Journal article

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

MR Cappelletti, L Gnetti, D Santini, D Spada, SB Fox, D Generali

Oncoscience | Published : 2015

DOI: 10.18632/oncoscience.168

Open access

Download PDF

University of Melbourne Researchers

Citation metrics

3Scopus
3Dimensions

Keywords

3211 Oncology and Carcinogenesis
Cancer
Everolimus
32 Biomedical and Clinical Sciences
Endometrial Cancer
Women'S Health
Fgfr2
Uterine Cancer
6.1 Pharmaceuticals
Fgfr Inhibitors
Estrogen